INTRODUCTION
Walker's observation (1) that neostigmine,2 a choline esterase inhibitor, benefited patients with myasthenia gravis, suggested that the acetylcholine metabolism was disturbed in such patients. Assuming that this conception has validity, the dominant possibilities concerning myasthenia gravis are: (a) excessive destruction of acetylcholine, due to unusually large amounts of choline esterase; (b) defects in the ability of muscle to respond to acetylcholine; and (c) defects in the synthesis or release of acetylcholine.
The choline esterase level of the serum is not unusual in patients with myasthenia gravis, as was shown by Milhorat (2) . Lanari (3) , and Harvey and collaborators (4 to 6) demonstrated that the skeletal muscle of patients with myasthenia gravis is capable of reacting to acetylcholine and, indeed, is especially sensitive. Harvey and Lilienthal (5) suggested that this increased sensitivity represented a change in muscle threshold because of its exposure to diminishing amounts of acetylcholine.
The most plausible hypothesis is that there exists a fundamental defect in the synthesis of acetylcholine in patients with myasthenia gravis. Dr. Otto Loewi suggested that such synthesis be investigated.3
MATERIAL
The sera of 5 healthy subjects and 59 patients with diseases other than myasthenia gravis were used as controls. Summaries of the clinical state of 9 patients with myasthenia gravis are presented in Table I . In the ninth patient (N), the diagnosis of myasthenia gravis, although probable, was difficult to establish. 1 This study was aided by a grant from the Josiah Macy, Jr. Foundation. 2 Prostigmine (Hoffmann-La Roche). 3 We are immeasurably indebted to Dr. Loewi for his enthusiastic interest in the development of the problem, and for his valuable advice on technic.
EFFECT OF HUMAN SERUM ON THE SYNTHESIS OF ACETYLCHOLINE
Principles and outline of method. The method of Quastel, Tennenbaum, and Wheatley (7) was modified for use in this demonstration. The bases of the method utilized are: (a) uniform samples of nerve tissue under standard environmental conditions will synthesize acetylcholine at a fixed rate; (b) the amount of acetylcholine thus synthesized may be biologically assayed by measuring its effect in inducing contraction in a properly sensitized muscle. The relative ability of 2 media to influence the synthesis of acetylcholine can thus be measured. In this series of experiments, the nerve tissue was frog brain. The indicator of acetylcholine content was the rectus abdominis muscle of the frog. The effect on acetylcholine synthesis of sera from patients with myasthenia gravis was compared with the effect on acetylcholine synthesis of control sera.
CoUection and preparation of samples. The frog brain4 medium was prepared by mincing with scissors the freshly dissected whole brains of 10 to 25 frogs. Hundred mgm. samples were rapidly weighed from this homogeneous stock.
Blood samples were usually collected before breakfast. All blood samples were immediately defibrinated by shaking with glass perles for 5 minutes, and then promptly centrifuged. The supernatant serum was used for analysis. Only clear yellow sera were used and specimens with hemolysis were discarded. From each individual serum, specimens in triplicate were prepared as follows: 1 cc. of serum was mixed with 100 mgm. of frog brain, 1 cc. of Ringer's solution at pH 7. Incubation. The mixtures were placed in vessels mounted on a shaking machine and shaken and, incubated for 4 hours in a water bath. At short intervals through- 4 The results were more uniform and small differences in the synthesis in the presence of serum were more readily demonstrable with frog brain than with mammalian brain. These preliminary steps completed, the muscle was immersed for 2 minutes in one of the unknown solutions. Then, after measuring the contraction induced by the unknown solution, the muscle was immersed in sequence in a series of standard acetylcholine solutions, of concentrations covering the range of the unknown solutions. The acetylcholine content was thus ascertained for each unknown solution.
Assay of acetylcholine synthesis. The acetylcholine content of the mixtures, enumerated in Table II , was assayed.
It has been suggested (10, 11) that boiling brain tissue makes available the intracellular bound acetylcholine. Therefore these assay procedures were repeated after boiling. The residue of brain previously removed by centrifugation was suspended in the diluted supernatant fluid used in the above described procedure, and the whole boiled for 2 minutes at pH 6.8. It was then re-centrifuged and the supernantant fluid assayed for acetylcholine content by measuring the magnitude of contraction of the rectus abdominis muscle of frog as described above.
The stability of the muscle was tested before and after the assay of each unknown solution by immersion in standard acetylcholine solutions.
The acetylcholine content of each mixture was assayed on 2 to 12 different rectus abdominis muscle preparations. Thus, calculations on acetylcholine synthesis in each individual serum specimen were based on results obtained from at least 5 muscles.
Demonstration that the contractions induced by the mixtures are due to acetylcholine. To be certain that the contraction was induced by acetylcholine contained in the unknown solution and not by other substances, the muscles were immersed in the same unknown solution before and after being sensitized by immersion in physostigmine. Since only acetylcholine effects are significantly modified by physostigmine, it was inferred that any contraction that was augmented by physostigmine was due to acetylcholine. (Tables  V and VI) .
The most serious decrease in the synthesis of acetylcholine was noted in the mixtures containing serum from the patients most seriously ill with myasthenia gravis. The samples from the patient with the least impairment (N), constituting a borderline myasthenic state, presented a defect in synthesis barely below the level of some of the controls (Tables V and VI) . 6 While this paper was in press, results similar to those of case S were obtained using serum of 3 additional and comparable patients with myasthenia gravis. Incubated mixtures containing serum collected before and after the administration of 15 mgm. neostigmine bromide by mouth to 2 healthy adults, yielded similar acetylcholine content. All patients with-myasthenia gravis were taking neostigmine bromide during these experiments. Blood samples were collected both before and after the morning medication. No significant difference between the 2 sets of blood samples was noted as regards acetylcholine synthesis.
Series 2. The effect on acetylcholine synthesis of the mixture of the control serum and the serum from patients with myasthenia gravis A mixture of the serum of controls and the serum from patients with myasthenia gravis synthesized at 380 C. an amount of acetylcholine approximately equivalent to the sum of the synthesis of the 2 sera. Series 3. Effect of the dialysate of serum on the synthesis of acetylcholine To ascertain whether the factors which modify the synthesis of acetylcholine in the frog brain in vitro are dialyzable, serum was dialyzed through a semi-permeable cellophane membrane. Three cc. of serum were placed in a flat glass container (4 cc. volume), separated from another similar glass container by a cellophane membrane. This second vessel contained 3 cc. of Ringer's solution (mammalian type) and the apparatus was shaken for 4 hours at 230 C. The effect of the dialysate on the acetylcholine synthesis was then compared with the effect of Ringer's solution: 2 cc. of dialysate and 2 cc. of Ringer's solution were added to mixtures of frog brain. glucose, and physostigmine, incubated, and assayed as described above. The results are summarized in Table VII (12) .
This difference is significant, since variation from subject to subject, both among the healthy and among those with diseases other than myasthenia gravis, was less than ± 15 per cent, and it was usually under i 10 per cent. The difference in acetylcholine synthesis between samples of serum of different patients with myasthenia gravis was considerable, but the variation in the sample of serum of any one myasthenic patient was less than ±-15 per cent. The serum from patient H with severe myasthenia gravis was examined over a long period during which the clinical state changed slightly. This may have a bearing on the wider variation (-20, + 15 per cent from the average) observed in this patient. Hence, the usually more than 100 per cent greater synthesis of acetylcholine with control serum, as compared with the serum from patients seriously incapacitated by myasthenia gravis, represents a major difference in the nature of the serum samples. 7 Moreover, this reduction of acetylcholine synthesis is not an expression of debility, cachexia, immobility, or prostration.
It is of interest that the magnitude of the decrease in acetylcholine synthesis is related to the severity of the myasthenia gravis in this small group of patients. The serum from patients with the more serious clinical disability supported acetylcholine synthesis less well than did serum of patients in a better clinical state. With the method now employed, the determinable reduction in the less seriously ill is so small that obviously this technic is not of value for diagnostic purposes. 7 The spinal fluid from patients with myasthenia gravis exerts a similar effect on the synthesis of acetylcholine to that of the serum (13) .
While this paper was in press, Stoerk and Morpeth (14), using rat brain as a source of enzyme, reported that they could detect no difference in the amounts of acetylcholine synthesized in the presence of serum from control subjects and serum from patients with myasthenia gravis. Since they were also unable to demonstrate any difference in the amounts of acetylcholine synthesized in the presence of control serum as compared to Locke's solution, it is inferred that their adaptation of the method of Quastel, Tennenbaum, and Wheatley was not adequate for the demonstration of such differences in the synthesis of acetylcholine as are relevant to this discussion.
Since the dialysate of serum affects acetylcholine synthesis, it may be inferred that some of the modifying agents, both potentiators and depressors, are of a relatively small molecular size and not colloidal in nature.
Since acetylcholine synthesis is greater in frog brain-Ringer's solution-control serum mixtures than in frog brain-Ringer's solution mixtures, it is likely that the serum furnishes additional substrate to the enzyme responsible for acetylcholine synthesis. Also, a temperature of 380 C., that interferes with acetylcholine synthesis in frog brain-Ringer's solution mixtures, permits, in frog brain-Ringer's solution-serum mixtures, more synthesis than is found at 230 C. Apparently at 380 C., this particular enzyme is more active than at 230 C., and though the substrate contributed by frog brain is converted at 380 C. into a state less suitable for acetylcholine synthesis, the substrate added by the serum compensates for the loss.
The decrease in acetylcholine synthesis demonstrated in these in vitro studies suggests that there may be similar defects in acetylcholine synthesis in patients with myasthenia gravis. There is reason to assume that the serum of patients with myasthenia gravis which poorly supports acetylcholine synthesis in vitro acts similarly in vivo.
It seems probable that in patients with myasthenia gravis, the acetylcholine available at the synapses eventually becomes insufficient for effective and repeated contraction of the muscle. Neostigmine aids these patients by impeding the breakdown of the diminished quantities of acetylcholine. SUMMARY 1. Using frog brain-serum and frog brainRinger's solution mixtures as preparations for studying rate of acetylcholine synthesis, and the sensitized rectus abdominis muscle of frog for bioassay of acetylcholine content of the mixtures, the effect of control sera and sera from patients with myasthenia gravis on acetylcholine synthesis was investigated.
2. In frog brain-Ringer's solution mixtures, acetylcholine synthesis is greater at 230 C. than at 380 C., while the reverse is true of frog brainserum mixtures.
3. Acetylcholine synthesis in frog brain-control serum mixtures or in frog brain-dialysate of control serum mixtures exceeded that from frog brain-Ringer's solution mixtures.
4. Acetylcholine synthesis in mixtures of frog brain and serum from patients with myasthenia gravis was significantly less than that in frog brain-control serum mixtures. The more severe the myasthenia gravis, the less the acetylcholine synthesis. In mixtures of frog brain and dialysate of serum from patients with myasthenia gravis, acetylcholine synthesis was less than in mixtures of frog brain-Ringer's solution.
5. These results suggest that there is a defect in acetylcholine synthesis in patients with myasthenia gravis which can explain the fatiguability and weakness of these patients.
